Pharmacovigilance Specialist at Startup
High Conscientiousness and Openness to detect safety signals, manage PSURs, and keep the PV system regulatory compliant.
In pharma startups, time to regulatory approval defines survival
Intellectual property and patents are strategic assets from day one
Partnerships with academic institutions accelerate development with less capital
Ideal OCEAN+ Profile
At startups (1-50 employees), analytical ability to detect emerging signals in safety data, interpret trends, and propose complex risk-benefit assessments
At startups (1-50 employees), rigor in case follow-up, generating periodic reports, keeping SOPs current, and meeting reporting obligations to agencies
At startups (1-50 employees), presenting safety findings to internal committees and regulatory agencies; communicating PV system updates across the organization
At startups (1-50 employees), collaboration with medical affairs, regulatory, clinical, and legal for comprehensive management of product safety obligations
At startups (1-50 employees), managing stress from critical safety signals that require fast regulatory response and decisions that affect product availability
At startups (1-50 employees), the pharmacovigilance specialist sustains the periodic reporting cycle (PSUR/PBRER), signal management, and risk-evaluation SOPs; process adherence is what makes the safety dossier defensible under inspection
Strengths and Red Flags
Strengths
- Detection and evaluation of emerging safety signals using robust statistical methodologies
- Management of PSURs, PADERs, and benefit-risk reports with high documentation quality
- Agile navigation of the regulatory process for new molecules or devices with a small team
- Managing strategic partnerships with research institutions and laboratories
Red Flags
- Mechanical case processing without a signal-detection mindset, turning PV into a bureaucratic process
- Missed reporting deadlines that expose the company to regulatory action
- Underestimates the time and cost of the regulatory process
- Prioritizes development speed over rigor in GMP documentation
Interview Questions
Have you ever detected an emerging safety signal? Describe what data alerted you, what evaluation methodology you used, and what regulatory action followed.
Evaluates: Analytical Openness and rigor in signal detection and evaluation
How many PSURs or PADERs have you prepared? Describe your process for generating the Benefit-Risk Summary and the most common errors you avoid.
Evaluates: Conscientiousness and technical mastery of periodic safety reporting
How did you navigate the regulatory process for your first molecule/device with a small team?
Evaluates: Conscientiousness and regulatory pragmatism
How did you prioritize with a limited development pipeline and capital?
Evaluates: Strategic decision-making ability under severe constraints
More about Pharmacovigilance Specialist
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Pharmacovigilance Specialist — base profile with no company context
View profile → SMB (51-200 employees)In SMB pharma, quality and compliance are the license to operate
View profile → Enterprise (201-1000 employees)In enterprise pharma, multi-market regulatory complexity is the norm
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →Does your next Pharmacovigilance Specialist at Startup (1-50 employees) match this profile?
Map anyone's OCEAN+ profile with the Talent Diagnostic: free, no signup, 10 minutes.
20 statements · 10 minutes · no card